Regeneron Pharmaceuticals Inc. buy Evercore ISI
Start price
14.05.24
/
50%
€909.80
Target price
14.05.25
€1,064.2
Performance (%)
-43.88%
End price
15.05.25
€510.60
Summary
This prediction ended on 15.05.25 with a price of €510.60. The BUY prediction by Evercore_ISI for Regeneron Pharmaceuticals Inc. performed very badly with a performance of -43.88%. A total of €0.84 was paid as dividends for this prediction. Evercore_ISI has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 2.399% | 2.399% | -10.766% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Evercore_ISI for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $1,150.00 price target on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Evercore_ISI for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€859.80
24.10.24
24.10.24
€1,087.7
24.10.25
24.10.25
-42.02%
25.10.25
25.10.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€899.00
16.05.24
16.05.24
-
16.05.25
16.05.25
-41.09%
17.05.25
17.05.25